These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Bromocriptine therapy of prolactinoma in pregnancy]. Nehmzow M; Ventz M; Meng W Zentralbl Gynakol; 1985; 107(14):899-903. PubMed ID: 4036407 [TBL] [Abstract][Full Text] [Related]
3. Hyperprolactinemia: current concepts of management including medical therapy with bromocriptine. Thorner MO; Evans WS; MacLeod RM; Nunley WC; Rogol AD; Morris JL; Besser GM Adv Biochem Psychopharmacol; 1980; 23():165-89. PubMed ID: 7395611 [No Abstract] [Full Text] [Related]
4. [Results of treatment in the hyperprolactinemic anovulatory syndrome]. Justus B; Richter B; Seiler E; Held HJ; Köhler K; Schaps P Zentralbl Gynakol; 1985; 107(21):1296-9. PubMed ID: 4082817 [TBL] [Abstract][Full Text] [Related]
5. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states. Abraham G Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300 [No Abstract] [Full Text] [Related]
6. Ergot drugs in the treatment of endocrine disorders: introduction. Kleinberg DL; Frantz AG Adv Biochem Psychopharmacol; 1980; 23():143-6. PubMed ID: 7395608 [No Abstract] [Full Text] [Related]
7. Treatment of hyperprolactinemias: a matter of controversy. Carmina E; Jannì A Acta Eur Fertil; 1983; 14(4):241-7. PubMed ID: 6673443 [No Abstract] [Full Text] [Related]
8. [The results of using parlodel in hyperprolactinemia]. Mel'nichenko GA; Gitel' EP; Romantsova TI Probl Endokrinol (Mosk); 1990; 36(3):29-33. PubMed ID: 2395828 [TBL] [Abstract][Full Text] [Related]
9. [Visual and neurological disturbances accompanying with pregnancies of hyperprolactinemic patients]. Takahashi A; Su JH; Motohashi T; Horie K; Tojo S Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):665-73. PubMed ID: 6864025 [TBL] [Abstract][Full Text] [Related]
18. [New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma]. Geyer G Wien Med Wochenschr; 1980 Aug; 130(15-16):501-9. PubMed ID: 6258331 [No Abstract] [Full Text] [Related]
19. [Inhibition of prolactin release by methysergide and bromocriptine in hyperprolactinemic subjects: comparative dynamic studies (author's transl)]. Fossati P; Dewailly D; Lemaire A; Cappoen JP; Wemeau JL; Fourlinnie JC; Linquette M Ann Endocrinol (Paris); 1980; 41(1):55-6. PubMed ID: 7396395 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic use of bromocriptine in women with amenorrhea-galactorrhea and suspected pituitary microadenoma. Jewelewicz R Adv Biochem Psychopharmacol; 1980; 23():209-15. PubMed ID: 7395612 [No Abstract] [Full Text] [Related] [Next] [New Search]